Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

NCT04826588 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS)

Interventions

DRUG: Methylprednisolone sodium succinate 10 mg/kg intravenously
BIOLOGICAL: Human normal immunoglobulin (IVIg)

Sponsor

University Children's Hospital Basel

Collaborators

[object Object]